Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06520345 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 430 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Telix Pharmaceuticals (Innovations) Pty Limited |
| Last Updated on CT.gov | July 10, 2025 (Jul 10, 2025) |
As of March 2, 2026: Clinical trial NCT06520345 is currently recruiting participants. This clinical trial study for prostate cancer is actively seeking new participants at 9 locations across the United States. The study is sponsored by Telix Pharmaceuticals (Innovations) Pty Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06520345 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06520345 was last updated Jul 10, 2025 (July 10, 2025). HelloStudys verifies this status automatically.